Pulse Biosciences (PLSE) Income from Continuing Operations (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Income from Continuing Operations of 29961000.0 for Q3 2025, down 136.29% year-over-year from 82570197.78 in Q3 2024, and down 56.31% quarter-over-quarter from 19168000.0 in Q2 2025.
Pulse Biosciences (PLSE) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Pulse Biosciences' Income from Continuing Operations history runs 11 years deep, the most recent figure standing at 29961000.0 for Q3 2025.
- In Q3 2025, Income from Continuing Operations fell 136.29% year-over-year to 29961000.0; the TTM figure through Sep 2025 stood at 21876000.0 (up 147.42% YoY), while the FY2025 annual figure was 72800000.0, up 35.82% from the prior year.
- Income from Continuing Operations for Q3 2025 stood at 29961000.0, down from 19168000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 87800000.0 in Q4 2024, with the low at 29961000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 13996000.0 (2022), against an average of 9701052.63.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 835.77% in 2024, then sank 136.29% in 2025.
- Pulse Biosciences' Income from Continuing Operations stood at 15463000.0 in 2021, then surged by 40.52% to 9197000.0 in 2022, then fell by 29.75% to 11933000.0 in 2023, then surged by 835.77% to 87800000.0 in 2024, then plunged by 134.12% to 29961000.0 in 2025.
- Business Quant data shows PLSE's Income from Continuing Operations at 29961000.0 in Q3 2025, 19168000.0 in Q2 2025, and 16795000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | -24.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -187.97 Mn |
| Sep 30, 2025 | -29.96 Mn |
| Jun 30, 2025 | -19.17 Mn |
| Mar 31, 2025 | -16.80 Mn |
| Dec 31, 2024 | 87.80 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -11.38 Mn |
| Mar 31, 2024 | -10.14 Mn |
| Dec 31, 2023 | -11.93 Mn |
| Sep 30, 2023 | -10.57 Mn |
| Jun 30, 2023 | -9.91 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -9.20 Mn |
| Sep 30, 2022 | -18.04 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | -17.27 Mn |
| Dec 31, 2021 | -15.46 Mn |
| Sep 30, 2021 | -14.94 Mn |
| Jun 30, 2021 | -20.31 Mn |
| Mar 31, 2021 | -20.57 Mn |